Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Jazz 1b CPX-351 previously untreated AML
Clinical Trial Grant
Duke Scholars
Principal Investigator
Harry Paul Erba
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Jazz Pharmaceuticals
Start Date
April 2, 2020
End Date
July 25, 2024
Awarded By
Jazz Pharmaceuticals
Start Date
April 2, 2020
End Date
July 25, 2024
